Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy... Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. 詳細を表示
Fourth Quarter Revenue Approximately $15.1 Million and Full Year Total Revenue Approximately $37.2 Million Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional...
Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the...
Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced the...
Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that the U.S. Food and Drug...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.1301 | 17.869966443 | 11.92 | 14.31 | 11.38 | 615678 | 12.87926555 | CS |
4 | 2.9001 | 26.0098654709 | 11.15 | 14.31 | 10.75 | 408763 | 12.41864832 | CS |
12 | 3.4001 | 31.9258215962 | 10.65 | 14.31 | 8.87 | 411776 | 11.24214184 | CS |
26 | 6.1301 | 77.4002525253 | 7.92 | 14.31 | 7.1701 | 351509 | 10.33391987 | CS |
52 | 10.0901 | 254.800505051 | 3.96 | 14.31 | 3.7 | 293141 | 8.5863743 | CS |
156 | 7.0901 | 101.869252874 | 6.96 | 14.31 | 2.25 | 337674 | 6.12049536 | CS |
260 | 10.2801 | 272.681697613 | 3.77 | 25.18 | 2.25 | 250704 | 7.09005065 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約